ACTA1 and hepatocellular carcinoma: CAFs, characterized by α-SMA expression, promote tumour progression by directly or indirectly stimulating tumour cell proliferation, and invasion, and by enhancing angiogenesis, which is the main cause of a poor prognosis in HCC patients [28, 29].